Added to YB: 2024-10-17
Pitch date: 2024-10-17
ICAD [bullish]
iCAD, Inc.
+21.88%
current return
Author Info
Multibagger Monitor focuses on event-driven, reflexive, and microcap situations with the potential to appreciate rapidly in <2 years. Sign up for the newsletter.
Company Info
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.
Market Cap
EUR 41.9M
Pitch Price
EUR 1.60
Price Target
9.75 (+400%)
Dividend
N/A
Sector
Health Care Technology
Category
growth
AI Radiology Company Transitioning to Cloud w/ Multibagger Potential ($ICAD)
ICAD: AI mammography leader at multi-decade lows. Transitioning to cloud SAAS model, potential $30M+ ARR from existing customers. Near breakeven, 85%+ margins. $20M net cash. 23% more cancers detected, 50% faster reads. Partnerships with Google, NVIDIA, GE. Risk: Hologic dominance. Catalyst: December radiology conference.
Read full article (11 min)